Advertisement
Loading...

Viatris Inc.

VTRS•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$16.48
$-0.78(-4.52%)
U.S. Market opens in 28h 24m

Viatris Inc. (VTRS) Stock Overview

Explore Viatris Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap19.2B
P/E Ratio-64.21
EPS (TTM)$-0.30
ROE-0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$17.56
3 Months$22.94
1 Year Target$15.04

VTRS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Viatris Inc. (VTRS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.49, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $15.04.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -64.21 and a market capitalization of 19.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.52%
5-Day Change
-4.74%
1-Month Change
18.90%
3-Month Change
4.50%
6-Month Change
53.73%
Year-to-Date (YTD) Change
32.37%
1-Year Change
87.49%
3-Year Change
75.88%
5-Year Change
2.04%
All-Time (Max) Change
32860.00%

Contact Information

https://www.viatris.com
724 514 1800
1000 Mylan Boulevard, Canonsburg, PA, 15317

Company Facts

32,000 Employees
IPO DateMar 17, 1980
CountryUS
Actively Trading

Frequently Asked Questions